Association of haemoglobin levels in the first trimester and at 26–30 weeks with fetal and neonatal outcomes: a secondary analysis of the Global Network for Women’s and Children’s Health’s ASPIRIN Trial

S, Jessan; S, Saleem; MK, Hoffman; SS, Goudar; RJ, Derman; JL, Moore; A, Garces; L, Figueroa; NF, Krebs; J, Okitawutshu; A, Tshefu; CL, Bose; M, Mwenechanya; E, Chomba; WA, Carlo; PK, Das; A, Patel; PL, Hibberd; F, Esamai; EA, Liechty; S, Bucher; TL, Nolen; M, Koso-Thomas; M, Miodovnik; EM, McClure; RL, Goldenberg

Association of haemoglobin levels in the first trimester and at 26–30 weeks with fetal and neonatal outcomes: a secondary analysis of the Global Network for Women’s and Children’s Health’s ASPIRIN Trial

S, Jessan; S, Saleem; MK, Hoffman; SS, Goudar; RJ, Derman; JL, Moore; A, Garces; L, Figueroa; NF, Krebs; J, Okitawutshu; A, Tshefu; CL, Bose; M, Mwenechanya; E, Chomba; WA, Carlo; PK, Das; A, Patel; PL, Hibberd; F, Esamai; EA, Liechty; S, Bucher; TL, Nolen; M, Koso-Thomas; M, Miodovnik; EM, McClure; RL, Goldenberg

URI: http://41.89.205.12/handle/123456789/1823

Date: 2021-04-12

Abstract:

Limited data are available from low- and middleincome countries (LMICs) on the relationship of haemoglobin levels to adverse outcomes at different times during pregnancy. We evaluated the association of haemoglobin levels in nulliparous women at two times in pregnancy with pregnancy outcomes

Show full item record